600624 Stock Overview
Operates in software development, biomedicine, real estate, and other businesses. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shanghai Fudan Forward S&T Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.93 |
| 52 Week High | CN¥9.50 |
| 52 Week Low | CN¥2.76 |
| Beta | 0.49 |
| 1 Month Change | 42.37% |
| 3 Month Change | 137.43% |
| 1 Year Change | 40.11% |
| 3 Year Change | 17.13% |
| 5 Year Change | -17.48% |
| Change since IPO | 350.44% |
Recent News & Updates
Revenues Not Telling The Story For Shanghai Fudan Forward S&T Co., Ltd (SHSE:600624) After Shares Rise 27%
Nov 25
What Shanghai Fudan Forward S&T Co., Ltd's (SHSE:600624) 33% Share Price Gain Is Not Telling You
Oct 01Solid Earnings May Not Tell The Whole Story For Shanghai Fudan Forward S&T (SHSE:600624)
Sep 06Recent updates
Revenues Not Telling The Story For Shanghai Fudan Forward S&T Co., Ltd (SHSE:600624) After Shares Rise 27%
Nov 25What Shanghai Fudan Forward S&T Co., Ltd's (SHSE:600624) 33% Share Price Gain Is Not Telling You
Oct 01Solid Earnings May Not Tell The Whole Story For Shanghai Fudan Forward S&T (SHSE:600624)
Sep 06What Shanghai Fudan Forward S&T Co., Ltd's (SHSE:600624) 32% Share Price Gain Is Not Telling You
Jul 24Some Confidence Is Lacking In Shanghai Fudan Forward S&T Co., Ltd (SHSE:600624) As Shares Slide 29%
Jun 06Shanghai Fudan Forward S&T Co., Ltd's (SHSE:600624) Share Price Could Signal Some Risk
Feb 27Shareholder Returns
| 600624 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.1% | -1.9% | -1.2% |
| 1Y | 40.1% | -1.8% | 11.8% |
Return vs Industry: 600624 exceeded the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 600624 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility
| 600624 volatility | |
|---|---|
| 600624 Average Weekly Movement | 13.5% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600624's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 600624's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,363 | n/a | www.forwardgroup.com |
Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations, as well as chemical raw materials, digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory system drugs, and traditional and modern Chinese medicines. It is also involved in the development of high-tech parks; and development, production, and sale of uninterruptible power supplies and lead-acid batteries, as well as professional agent of car audio brand.
Shanghai Fudan Forward S&T Co., Ltd Fundamentals Summary
| 600624 fundamental statistics | |
|---|---|
| Market cap | CN¥5.39b |
| Earnings (TTM) | -CN¥33.16m |
| Revenue (TTM) | CN¥638.98m |
8.4x
P/S Ratio-162.5x
P/E RatioIs 600624 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600624 income statement (TTM) | |
|---|---|
| Revenue | CN¥638.98m |
| Cost of Revenue | CN¥399.12m |
| Gross Profit | CN¥239.87m |
| Other Expenses | CN¥273.03m |
| Earnings | -CN¥33.16m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.049 |
| Gross Margin | 37.54% |
| Net Profit Margin | -5.19% |
| Debt/Equity Ratio | 47.0% |
How did 600624 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 03:47 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Fudan Forward S&T Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|